• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

KRAS inhibitor-9

CAS No. 300809-71-6

KRAS inhibitor-9 ( DUN09716 )

产品货号. M22747 CAS No. 300809-71-6

KRAS抑制剂-9是一种有效的KRAS抑制剂,Kd为92 μM,可阻断GTP-KRAS的形成和KRAS下游的激活。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥632 有现货
5MG ¥988 有现货
10MG ¥1604 有现货
25MG ¥3013 有现货
50MG ¥4358 有现货
100MG ¥5589 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    KRAS inhibitor-9
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    KRAS抑制剂-9是一种有效的KRAS抑制剂,Kd为92 μM,可阻断GTP-KRAS的形成和KRAS下游的激活。
  • 产品描述
    KRAS inhibitor-9 is a potent KRAS inhibitor with Kd of 92 μM that blocks the formation of GTP-KRAS and downstream activation of KRAS.??KRAS inhibitor-9 causes G2/M cell cycle arrest and induces apoptosis. KRAS inhibitor-9 selectively inhibits the proliferation of NSCLC cells with KRAS mutation but not normal lung cells
  • 体外实验
    KRAS inhibitor-9 bound to KRASG12D, KRAS G12C and KRAS Q61H protein with a moderate binding affinity of -5.38, -5.41, and -3.97 kcal/mol, respectively. KRAS inhibitor-9 (0-100 μM) shows strong inhibition selectivity in NSCLC cells with IC50s ranging from 39.56 to 66.02 μM for H2122, H358 and H460 cells (at 72 hours).KRAS inhibitor-9 (0-100 μM; 24 hours) blocks GTP-KRAS formation in H2122, H358 and H460 cells.KRAS inhibitor-9 (25-100 μM; 48 hours) inhibits the activation of KRAS downstream signaling pathway.KRAS inhibitor-9 (0-100 μM; 24-72 hours) induces cell cycle arrest and apoptosis in NSCLC. Cell Viability Assay Cell Line:H2122 (KRAS G12C), H358 (KRAS G12C) and H460 (KRAS Q61H) cell lines Concentration:0, 25, 50, 100 μM Incubation Time:24, 48, and 72 hoursResult:Inhibited three NSCLC cell lines in a dose- and time-dependent manner, but not in normal lung fibroblast cell line CCD-19Lu.Western Blot Analysis Cell Line:H2122, H358 and H460 cells Concentration:0, 25, 50, 100 μM Incubation Time:48 hours Result:Reduces the levels of phosphorylation of CRAF and AKT in a dose-dependent manner in H2122, H358 and H460 cells.Apoptosis Analysis Cell Line:H2122, H358, H460 cellsConcentration:0, 25, 50, 100 μM Incubation Time:24-72 hours Result:Significantly decreased in G0/G1 phase while remarkably increased in G2/M phase after 24 hours and induced a significantly increased apoptosis for 48h in NSCLC cell lines.
  • 体内实验
    ——
  • 同义词
    DUN09716
  • 通路
    MAPK/ERK Signaling
  • 靶点
    Ras
  • 受体
    KRAS
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    300809-71-6
  • 分子量
    292.8
  • 分子式
    C13H9ClN2S2?
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:230 mg/mL?(785.49 mM;?Need ultrasonic)
  • SMILES
    Nc1ccc(Sc2nc3ccccc3s2)c(Cl)c1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Xie C, et al. Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells. Front Pharmacol. 2017;8:823. Published 2017 Nov 14.
产品手册
关联产品